Department of Pediatrics
Section of Hematology-Oncology and
Department of Orthopedics
Baylor College of Medicine
Elizabeth Olmsted-Davis, Ph.D.
One Baylor Plaza
Houston, TX 77030
Dr. Olmsted-Davis’s research program encompasses the development of a safe efficacious system for the production of bone. This gene therapy system utilizes a novel adenovirus vector to induce spine fusion and repair of fractures. The second area of interest is in the identification of stem cells for osteoblasts. Dr. Olmsted-Davis in collaboration with Dr. Alan Davis recently demonstrated that an early adult stem cell for the hematopoietic system also efficiently replenishes osteoblast pools in bone. The lab is currently identifying molecular and environmental triggers that lead to differentiation of the stem cells into bone forming cells. The lab is currently investigating the ability of this stem cell population to treat diseases such as osteoporosis.
Dr. Olmsted-Davis also manages the vector development core, which provides gene therapy vectors for use as gene therapy systems as well as for basic research tools for understanding gene/protein function.
Dr. Elizabeth Olmsted-Davis’ lab is part of the Center for Cell and Gene Therapy (CAGT) research laboratories.
Ph.D., University of Rochester
Post-doc, Wyeth-Ayerst Research
Johnson & Johnson Orthopaedic Research and Education
Fellowship, University of Pennsylvania
Fellowship, Baylor College of Medicine
Member, American Society of Gene Therapy
Member, American Society of Bone and Mineral Research
Production of bone
Spine fusion and repair of fractures
Identification of stem cells for osteoblasts
Gene therapy vectors